InsiderSignalSign in
← Insider buys
RETA

Reata Pharmaceuticals Inc

SVP and Chief Accounting Officer Bhaskar Anand sold $72K of Reata Pharmaceuticals Inc

Sold$71,725
$87.47Price
820Shares
−3%Stake

What RETA did after the filing

Filed Mar 6, copier in the same day
The stock from Mon, Mar 6 close, $88.51
+12.0%
S&P 500, same days
+2.8%

Measured over 30 trading days, to the Apr 18 close.

Traded Fri, Mar 3. Filed Mon, Mar 6, 11:31 AM ET, during the session. Returns use the Mar 6 close and the Apr 18 close. Not investment advice.